Stay updated with the latest clinical-research news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on clinical-research topics.
Mumbai, Apr 6 (PTI) India's healthcare and pharmaceutical sector is set to enter a capability-led growth phase, potentially creating 2 to 2.5 million new jobs by 2030, while 30 to 35 per cent of the workforce will likely need reskilling, according to a report released on Monday. The country's healthcare and pharmaceutical sector is moving into a capability-led growth phase, with hiring increasingly focused on specialisation and technology integration across hospitals, AYUSH, home and elder care ...Read More >
Ahmedabad: A woman resident doctor posted in the paediatric ward of Sola Civil Hospital has been transferred to non-medical duty for a month after the hospital superintendent ordered an inquiry into allegations of misconduct. Officials from the state health department said the inquiry must be completed within 10 days.According to hospital sources, the incident took place on Sunday night, when the doctor allegedly misbehaved with the relatives of a young girl admitted with fever and persistent co ...Read More >
New Delhi, Oct 20 (PTI) India had a largely inconsistent growth in clinical research related to cancer since 2001, despite a strong economic growth, suggesting that development could be a contributing factor towards disparities among the low and middle-income countries in cancer research, according to a new study. Cancer cases and deaths are projected to surge in the coming decades with low and middle-income countries expected to bear a disproportionate burden. However, researchers, including ...Read More >
Open-Source AI Tool by Yandex Detects Signs of Infant Cerebral Palsy With Over 90% Accuracy Open-Source AI Tool by Yandex Detects Signs of Infant Cerebral Palsy With Over 90% Accuracy 4 min read Last Updated : Oct 16 2025 | 2:10 PM IST PNN Mumbai (Maharashtra) [India], October 16: Yandex B2B Tech, together with the Yandex School of Data Analysis and St. Petersburg State Pediatric Medical University, has developed the world's first AI solution for assessing brain development in infants under ...Read More >
NEW DELHI: India accounts for 17% of the world's population and 20% of the global disease burden, yet fewer than four percent of international clinical trials are conducted in the country. This gap means Indian patients often wait years after global approvals to access breakthrough therapies. Now, a new initiative, aligning it with Central Drugs Standard Control Organisations (CDSCO) priorities to boost participation of government sites in Phase 3 and 4 trials, has trained nearly 400 professio ...Read More >
New Delhi [India], July 18: Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology and innovation, announced the India findings of its 10th annual Future Health Index (FHI) 2025 report. The findings point to a growing majority of healthcare professionals viewing artificial intelligence (AI) as a vital tool in the delivery of better patient care even as India faces rising healthcare demand and persistent workforce shortages. Also Read | PM Narendra Modi Launches Infrastructure Proj ...Read More >
Renowned Indian Cardiac Surgeon Dr. Lokeswara Rao Sajja Inducted as Associate Member of Prestigious Sigma Xi Scientific Research Honor Society Dr. Lokeswara Rao Sajja, Senior Consultant Cardiothoracic Surgeon at STAR Hospitals and Chairman of the Sajja Heart Foundation 2 min read Last Updated : Jul 08 2025 | 6:25 PM IST VMPL New Delhi [India], July 8: Dr. Lokeswara Rao Sajja, Senior Consultant Cardiothoracic Surgeon at STAR Hospitals and Chairman of the Sajja Heart Foundation, has been induc ...Read More >
VMPL New Delhi [India], July 8: Dr. Lokeswara Rao Sajja, Senior Consultant Cardiothoracic Surgeon at STAR Hospitals and Chairman of the Sajja Heart Foundation, has been inducted as an Associate Member of Sigma Xi, The Scientific Research Honor Society--one of the world oldest and most respected organizations dedicated to the advancement of science and research. Founded in 1886 at Cornell University, USA, Sigma Xi has a long legacy of supporting excellence in scientific research and fostering c ...Read More >
BENGALURU: The Health and Family Welfare Department has written to the Drug Controller General of India (DCGI), seeking an investigation into alleged unethical clinical trials at Bengaluru-based HCG Hospital, a well-known cancer care hospital chain. The department acted after Justice P Krishna Bhat, former chairperson of the Institutional Ethics Committee (IEC) at HCG, raised serious concerns and resigned earlier this year. His resignation followed complaints about how clinical trials were bein ...Read More >
Bengaluru: Global biopharmaceutical company AstraZeneca is investing Rs166 crore to expand its Bengaluru operations, creating 400 new jobs. The upgraded facility will support around 1,300 employees and enhance the company's capabilities in AI-driven R&D, global business services, IT, and digital health, strengthening its presence in India.This investment follows AstraZeneca's recent expansion of its Global Innovation and Technology Centre (GITC) in Chennai. The company's workforce in India will ...Read More >
New Delhi, Jun 5 (PTI) Tata Memorial Centre has tied up with Wipro GE HealthCare Technologies Inc to establish a Cancer Research & Innovation Centre. The collaboration aims to strengthen clinical research and academic engagement activities with the establishment of a 'Joint Working Group' to determine key project areas and a collaboration roadmap for the next five years, Tata Memorial Centre (TMC) said in a statement. "The government is adopting a strategic, policy-driven approach to fight can ...Read More >
, /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that the Company received marketing authorization in from National Medical (TASE:PMCN) Products Administration (NMPA) for the first domestically developed trophoblast cell-surface antigen 2 (TROP2)-directed antibody"drug conjugate (ADC) sacituzumab tirumotecan (sac-™T, formerly SKB264/MK-2870) for adult patients with unresectable locally advanced or metastatic triple negative breast cancer (TNBC) who ha ...Read More >
Stay updated with the latest None news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on None topics.